ArticleNaunyn-Schmiedeberg's archives of pharmacology2018

Nebivolol, a β-blocker abrogates streptozotocin-induced behavioral, biochemical, and neurophysiological deficit by attenuating oxidative-nitrosative stress: a possible target for the prevention of diabetic neuropathy.

Naini Bhadri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.